Glycopyrronium Bromide
- CAS No.
- 51186-83-5
- Chemical Name:
- Glycopyrronium Bromide
- Synonyms
- Glonium bromide;GLYCOPYRRONIUM BROMIDE;GlycopyrroniuM BroMide API;Glycopyrrolate Impurity 58;erythro-Glycopyrronium bromide;Glycopyrronium bromide (CHF 5259;Glycopyrronium Bromide / Glycopyrrolate;2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid (triglycine);(R*,S*)-3-[(Cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide;Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, bromide, (R*,S*)-
- CBNumber:
- CB91270476
- Molecular Formula:
- C19H28NO3.Br
- Molecular Weight:
- 0
- MDL Number:
- MFCD31381925
- MOL File:
- 51186-83-5.mol
| Melting point | 175℃ |
|---|---|
| solubility | Freely soluble in water, soluble in ethanol (96 per cent), very slightly soluble in methylene chloride. |
| InChI | InChI=1/C19H28NO3.BrH/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1/t17-,19-;/s3 |
| InChIKey | VPNYRYCIDCJBOM-SCHKGOGONA-M |
| SMILES | [N+]1(C)(C)CC[C@H](OC([C@](C2CCCC2)(O)C2=CC=CC=C2)=O)C1.[Br-] |&1:5,8,r| |
| FDA UNII | V92SO9WP2I |
Glycopyrronium Bromide Chemical Properties,Uses,Production
Description
Glycopyrronium bromide or NVA 237 is a once-daily inhaled antimuscarinic bronchodilator newly approved by the European Commission for use in stable COPD. It is characterized by a quaternary ammonium structure, which reduces its oral bioavailability and, consequently, the systematic effects of any swallowed portion of the drug. Animal studies suggest that there are fewer cardiovascular effects compared to tiotropium because of the higher affinity to M3 versus M2 muscarinic receptors. Human studies showed fast onset of action, sustained bronchodilatation for 24 h, reduced dynamic hyperinflation of the lungs, and improved exercise tolerance. Glycopyrronium bromide in COPD airways clinical trial series (GLOW1–3) are the major clinical trials studying the efficacy and safety of glycopyrronium[1].
Chemical Properties
White or almost white, crystalline powder.
Uses
Anticholinergic
Uses
erythro-Glycopyrronium Bromide is used in preparation of diester containing compounds for treating hyperhidrosis.
Definition
ChEBI: (2R,3S)-glycopyrronium bromide is a glycopyrronium bromide that has (2R,3S)-configuration. The racemate, ritropirronium bromide, is used for treatment of chronic obstructive pulmonary disease. It is an enantiomer of a (2S,3R)-glycopyrronium bromide.
Indications
Glycopyrronium bromide is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions, and to block cardiac vagal inhibitory reflexes during induction of anaesthesia and intubation when indicated. Glycopyrronium bromide may be used intraoperatively to counteract drug-induced or vagal traction reflexes with the associated arrhythmias. Glycopyrronium bromide protects against the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarising muscle relaxants.
Side effects
The following reported adverse reactions are extensions of glycopyrronium bromide’s fundamentalpharmacological actions:
Cardiovascular: Tachycardia, ventricular fibrillation, bradycardia, palpitation and arrhythmia, hypertension, hypotension, cardiac arrest, heart block, prolonged QTc interval.
Dermatological: Flushing and inhibition of sweating. Severe allergic reactions or drug idiosyncrasies including urticaria and other dermal manifestations, pruritus, dry skin.
Gastrointestinal: Nausea, vomiting, dry mouth, constipation, taste alterations, including loss of taste.
Genitourinary: Urinary hesitancy and retention, impotence.
Ocular: Blurred vision due to mydriasis, cycloplegia, photophobia, increased ocular tension.
Nervous System: Inhibition of transmission at neuromuscular junction, headache, nervousness, drowsiness, dizziness, seizure, insomnia, some degree of mental confusion, especially in the elderly, hyperexcitability in children.
Pregnancy and perinatal: Suppression of lactation.
Respiratory System: Respiratory arrest.
General: Hyperpyrexia, bloated feeling, anaphylaxis/anaphylactoid reaction, hypersensitivity. Injection site reactions including pruritus, oedema, erythema, pain have been reported rarely.
References
[1] Alexander G. Mathioudakis, Victoria Chatzimavridou-Grigoriadou, Georgios A. Mathioudakis.“Chapter 16 - Drugs that act on the respiratory tract.” 2014: 241-256.
Glycopyrronium Bromide Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shandong Risen-Sun Pharmaceutical Co., Ltd | +86-15552509998 +86-15621883869 | liutf@jewim.com.cn | China | 251 | 58 |
| Sinoway Industrial co., ltd. | 0592-5800732; +8613806035118 | xie@china-sinoway.com | China | 988 | 58 |
| Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 | Mandy@hangyubiotech.com | China | 10986 | 58 |
| Beijing Cooperate Pharmaceutical Co.,Ltd | 010-60279497 | sales01@cooperate-pharm.com | CHINA | 1803 | 55 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21632 | 55 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29871 | 58 |
| Anhui Dexinjia Biopharm Co., Ltd | +86-531-82371986 +86-15064117275 | sales01@jndxj.com | China | 291 | 58 |
| Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 | sales@chemdad.com | China | 39894 | 58 |
| Shenzhen Excellent Biotech Co., Ltd. | 13480692018 | ramyan@ex-biotech.com | CHINA | 954 | 58 |
| SHANGHAI T&W PHARMACEUTICAL CO., LTD. | +86-021-61551413 +8618813727289 | contact@trustwe.com | China | 5738 | 58 |
Related articles
- Glycopyrronium Bromide: Therapeutic Efficacy, Safety and Tolerability
- Glycopyrronium bromide is a white, odourless, crystalline powder, is approved as a bronchodilator for the symptomatic maintena....
- Jan 13，2025
- Glycopyrronium Bromide: Indications, Drug Classes and Side Effects
- Glycopyrronium Bromide, a novel long-acting muscarinic antagonist (LAMA) for once-daily use, has been approved for use as a br....
- Jun 20，2024
- Glycopyrronium: Interactions, Mechanism of Action and ADME Profiles
- Glycopyrronium is an anticholinergic agent used to treat hyperhidrosis, severe drooling, COPD, used with other medications to ....
- Feb 3，2023
View Lastest Price from Glycopyrronium Bromide manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2025-02-17 | Glycopyrronium Bromide
51186-83-5
|
US $0.00-0.00 / G | 100G | 99% | 20TONS | Sinoway Industrial co., ltd. | |
 |
2025-01-06 | erythro-Glycopyrronium bromide
51186-83-5
|
US $115.00 / g | 100g | 98% | 100kg | Baoji Guokang Bio-Technology Co., Ltd. | |
 |
2024-09-25 | Glycopyrronium Bromide
51186-83-5
|
US $0.00 / KG | 1KG | 99% | 20 TONS | Wuhan Senwayer Century Chemical Co.,Ltd |
-
- Glycopyrronium Bromide
51186-83-5
- US $0.00-0.00 / G
- 99%
- Sinoway Industrial co., ltd.
-
- erythro-Glycopyrronium bromide
51186-83-5
- US $115.00 / g
- 98%
- Baoji Guokang Bio-Technology Co., Ltd.
-
- Glycopyrronium Bromide
51186-83-5
- US $0.00 / KG
- 99%
- Wuhan Senwayer Century Chemical Co.,Ltd
51186-83-5(Glycopyrronium Bromide)Related Search:
1of4